During the past decade, Haywood Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Haywood Hospital" #1 sponsor was "Amgen" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Izana Bioscience Ltd." with 1 trials sponsored and "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Haywood Hospital" #1 collaborator was "Arthritis Research UK" with 1 trials as a collaborator, "Georgina Craig Associates Limited" with 1 trials as a collaborator, "Innovate UK" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Pro-Mapp Limited Company number 10152526" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Haywood Hospital" are "Arthritis, Psoriatic" (2 trials), "Axial Spondyloarthritis" (2 trials), "Psoriatic Arthritis" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Musculoskeletal Pain" (1 trials). Many other conditions were trialed in "Haywood Hospital" in a lesser frequency.

Most popular intervention types in "Haywood Hospital" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Guselkumab" (1 trials) and "Guselkumab 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Haywood Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Haywood Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Haywood Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Haywood Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".